Blood Type Predisposes to Certain Viral Infections
By LabMedica International staff writers Posted on 30 Apr 2012 |
Some strains of Rotavirus find their way into the cells of the gastrointestinal tract by recognizing antigens associated with the type A blood group.
Histo-blood group antigens are known to promote binding of Norovirus and Helicobacter pylori cells to intestinal cells, but this had never been demonstrated in Rotavirus, a major intestinal pathogen that is the leading cause of severe dehydration and diarrhea in infants around the world.
Scientists at Baylor College of Medicine (Houston, TX, USA) examined the structure of a key part of a strain of the virus known as P[14] which provides a clue to how the virus infects human cells. The scientists used various techniques including protein expression and purification, crystallization, glycan array screening, inhibition and infectivity assays, and hemagglutination assays.
In strains of Rotavirus that infect animals, the top of a spike on the virus attaches to the cell via a glycan, one of many sugars linked together to form complex branched-chain structures with a terminal molecule of sialic acid. The same did not appear to be true of virus strains that infect humans, and scientists believed the human Rotavirus strains were bound to glycans with an internal sialic acid molecule, but they did not know how this occurs.
The investigators determined the structure of the top of the virus spike domain, known as VP8*, and found that the type A glycan bound to the Rotavirus spike protein at the same place as the sialic acid would have in an animal Rotavirus. They used crystallography, to show subtle changes in the structure of the VP8* domain of the virus that allowed it to use the histo-blood group antigen A as a receptor. An antibody to the histo-blood group antigen A blocked infection by the virus into human intestinal cells in culture. The authors found humans infected with the P[14] strain had type A blood, but more studies are needed to confirm the connection.
B. V. Venkataram Prasad, PhD, the lead author and professor of biochemistry and molecular biology at Baylor College of Medicine, said, "We wondered how this genotype of Rotavirus recognized a cellular glycan. We did a glycan array analysis to see which glycans interacted with the top of the virus spike, called VP8*. No one expected this. Is there an emerging theme here with these intestinal pathogens? Do other viruses use these blood group antigens as a door to enter the cell? The question now is do different strains use other histo-blood group antigens in this way?" Further studies identified a second Rotavirus strain P[9] that uses the histo-blood group antigen as a receptor. The study was published online on April 15 2012 in the journal Nature.
Related Links:
Baylor College of Medicine
Histo-blood group antigens are known to promote binding of Norovirus and Helicobacter pylori cells to intestinal cells, but this had never been demonstrated in Rotavirus, a major intestinal pathogen that is the leading cause of severe dehydration and diarrhea in infants around the world.
Scientists at Baylor College of Medicine (Houston, TX, USA) examined the structure of a key part of a strain of the virus known as P[14] which provides a clue to how the virus infects human cells. The scientists used various techniques including protein expression and purification, crystallization, glycan array screening, inhibition and infectivity assays, and hemagglutination assays.
In strains of Rotavirus that infect animals, the top of a spike on the virus attaches to the cell via a glycan, one of many sugars linked together to form complex branched-chain structures with a terminal molecule of sialic acid. The same did not appear to be true of virus strains that infect humans, and scientists believed the human Rotavirus strains were bound to glycans with an internal sialic acid molecule, but they did not know how this occurs.
The investigators determined the structure of the top of the virus spike domain, known as VP8*, and found that the type A glycan bound to the Rotavirus spike protein at the same place as the sialic acid would have in an animal Rotavirus. They used crystallography, to show subtle changes in the structure of the VP8* domain of the virus that allowed it to use the histo-blood group antigen A as a receptor. An antibody to the histo-blood group antigen A blocked infection by the virus into human intestinal cells in culture. The authors found humans infected with the P[14] strain had type A blood, but more studies are needed to confirm the connection.
B. V. Venkataram Prasad, PhD, the lead author and professor of biochemistry and molecular biology at Baylor College of Medicine, said, "We wondered how this genotype of Rotavirus recognized a cellular glycan. We did a glycan array analysis to see which glycans interacted with the top of the virus spike, called VP8*. No one expected this. Is there an emerging theme here with these intestinal pathogens? Do other viruses use these blood group antigens as a door to enter the cell? The question now is do different strains use other histo-blood group antigens in this way?" Further studies identified a second Rotavirus strain P[9] that uses the histo-blood group antigen as a receptor. The study was published online on April 15 2012 in the journal Nature.
Related Links:
Baylor College of Medicine
Latest Clinical Chem. News
- ‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection
- Low-Cost Portable Screening Test to Transform Kidney Disease Detection
- New Method Uses Pulsed Infrared Light to Find Cancer's 'Fingerprints' In Blood Plasma
- Carbon Nanotubes Help Build Highly Accurate Sensors for Continuous Health Monitoring
- Paper-Based Device Boosts HIV Test Accuracy from Dried Blood Samples
- AI-Powered Raman Spectroscopy Method Enables Rapid Drug Detection in Blood
- Novel LC-MS/MS Assay Detects Low Creatinine in Sweat and Saliva
- Biosensing Technology Breakthrough Paves Way for New Methods of Early Disease Detection
- New Saliva Test Rapidly Identifies Paracetamol Overdose
- POC Saliva Testing Device Predicts Heart Failure in 15 Minutes
- Screening Tool Detects Multiple Health Conditions from Single Blood Drop
- Integrated Chemistry and Immunoassay Analyzer with Extensive Assay Menu Offers Flexibility, Scalability and Data Commutability
- Rapid Drug Test to Improve Treatment for Patients Presenting to Hospital
- AI Model Detects Cancer at Lightning Speed through Sugar Analyses
- First-Ever Blood-Powered Chip Offers Real-Time Health Monitoring
- New ADLM Guidance Provides Expert Recommendations on Clinical Testing For Respiratory Viral Infections
Channels
Molecular Diagnostics
view channel
Cheap Cell-Free DNA Based Test Accurately Predicts Preterm Birth
Preterm birth (PTB) occurs in around 11% of all births globally, leading to considerable morbidity and mortality for both mothers and their newborns. Identifying pregnancies at risk of PTB early in gestation... Read more
RNA Blood Test Detects Cancers and Resistance to Treatment
A newly developed blood test offers the ability to detect cancer, understand how cancer resists treatments, and assess tissue damage from non-cancerous conditions. This innovative test, created by researchers... Read moreHematology
view channel
New Scoring System Predicts Risk of Developing Cancer from Common Blood Disorder
Clonal cytopenia of undetermined significance (CCUS) is a blood disorder commonly found in older adults, characterized by mutations in blood cells and a low blood count, but without any obvious cause or... Read more
Non-Invasive Prenatal Test for Fetal RhD Status Demonstrates 100% Accuracy
In the United States, approximately 15% of pregnant individuals are RhD-negative. However, in about 40% of these cases, the fetus is also RhD-negative, making the administration of RhoGAM unnecessary.... Read moreImmunology
view channel
Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer
Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more
Machine Learning-Enabled Blood Test Predicts Immunotherapy Response in Lymphoma Patients
Chimeric antigen receptor (CAR) T-cell therapy has emerged as one of the most promising recent developments in the treatment of blood cancers. However, over half of non-Hodgkin lymphoma (NHL) patients... Read moreMicrobiology
view channel
Handheld Device Delivers Low-Cost TB Results in Less Than One Hour
Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more
New AI-Based Method Improves Diagnosis of Drug-Resistant Infections
Drug-resistant infections, particularly those caused by deadly bacteria like tuberculosis and staphylococcus, are rapidly emerging as a global health emergency. These infections are more difficult to treat,... Read more
Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours
Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read morePathology
view channel
Rapid, Ultra-Sensitive, PCR-Free Detection Method Makes Genetic Analysis More Accessible
Genetic testing has been an important method for detecting infectious diseases, diagnosing early-stage cancer, ensuring food safety, and analyzing environmental DNA. For a long time, polymerase chain reaction... Read more
Spit Test More Accurate at Identifying Future Prostate Cancer Risk
Currently, blood tests that measure the level of a protein called prostate-specific antigen (PSA) are commonly used to identify men at higher risk for prostate cancer. This test is typically used based... Read more
DNA Nanotechnology Boosts Sensitivity of Test Strips
Since the Covid-19 pandemic, most people have become familiar with paper-based rapid test strips, also known as lateral flow immunoassays (LFIAs). These tests are used to quickly detect biomarkers that... Read more
Novel UV and Machine Learning-Aided Method Detects Microbial Contamination in Cell Cultures
Cell therapy holds great potential in treating diseases such as cancers, inflammatory conditions, and chronic degenerative disorders by manipulating or replacing cells to restore function or combat disease.... Read moreTechnology
view channel
Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples
As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more
Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples
Chronic pain is a widespread condition that remains difficult to manage, and existing clinical methods for its treatment rely largely on self-reporting, which can be subjective and especially problematic... Read more
Innovative, Label-Free Ratiometric Fluorosensor Enables More Sensitive Viral RNA Detection
Viruses present a major global health risk, as demonstrated by recent pandemics, making early detection and identification essential for preventing new outbreaks. While traditional detection methods are... Read moreIndustry
view channel
Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions
Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Grifols and Tecan’s IBL Collaborate on Advanced Biomarker Panels
Grifols (Barcelona, Spain), one of the world’s leading producers of plasma-derived medicines and innovative diagnostic solutions, is expanding its offer in clinical diagnostics through a strategic partnership... Read more